Skip to main content
Clinical Trials/NCT05087199
NCT05087199UnknownNot Applicable

COVID-19 Infection in Patients With Chronic Pulmonary Diseases.

Sohag University0 sites100 target enrollmentStarted: November 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Primary Endpoint
Effect of COVID-19 on patients with chronic pulmonary diseases

Study Overview

Brief Summary

This study aims to assess the clinical presentation, radiological patterns and outcome of COVID-19 infection in patients with chronic pulmonary disease.

Inter-relationship between the severity of COVID-19 infection and chronic pulmonary diseases.

Detailed Description

The COVID-19 pandemic has led to many difficulties with the diagnosis and routine management of chronic pulmonary diseases such as COPD, Bronchial asthma, ILD and Bronchiectasis as well as raising concerns about the management and outcomes for patients with these diseases who develop COVID-19.

Although there is conflicting evidence on whether patients with chronic respiratory diseases are more susceptible to COVID-19, these patients exhibit a more severe presentation and higher mortality compared with those without chronic respiratory diseases.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
16 Years to 100 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects with confirmed diagnosis of COVID-19 infection by:
  • RT-PCR And Chest Computed tomography and laboratoty investigations. Patients with chronic chest disease including (COPD, bronchial asthma, ILD, bronchiectasis).

Exclusion Criteria

  • Those who are diagnosed with viral pneumonia caused by viruses other than COVID-
  • Those who are not confirmed to be COVID-19 with PCR or by radiological and laboratory investigations.

Outcomes

Primary Outcomes

Effect of COVID-19 on patients with chronic pulmonary diseases

Time Frame: 2 weeks after patient confirmation of infection by COVID-19

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mostafa Mahmoud Elsayed

Principal Investigator

Sohag University

Similar Trials